The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.512
Bid: 1.51
Ask: 1.514
Change: 0.00 (0.00%)
Spread: 0.004 (0.265%)
Open: 1.48
High: 1.528
Low: 1.48
Prev. Close: 1.512
CBKD Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EGM Resolutions - March 25th, 2024

26 Mar 2024 07:00

RNS Number : 1980I
Commercial Intnl Bank (Egypt) SAE
26 March 2024
 

 

1/2

 

Summary of Resolutions

of Extraordinary General Assembly

March 25th, 2024

 

Issuance of Financial Instruments

 

In light of Article (19) of the Bank's statute, and the Board of Directors' approval dated February 11, 2024, the Extraordinary General Assembly approved the following:

 

First: To delegate the Board of Directors to issue financial instruments (senior or subordinated bonds or subordinated Debt or subordinated deposits or hybrid financial instruments) to finance various business activities up to a maximum of one billion US dollars or their equivalent in local or other foreign currencies, in addition to the remaining balance of the approval issued during the Extraordinary General Assembly, which was held on 20 March 2023. All subordinated instruments can be included at the Bank Capital and/or Tier II recognition. The financial instruments could be tradable, and also could be subordinated (the bondholder or lender has to waive his repayment priority right) according to the discretion of the Board of Directors in accordance to the CBE regulations.

 

Second: To delegate the Board of Directors in determining the date and all terms of issuance and in amending any term as requested by the governing authorities or as viewed necessary by the Board in light of the market perceived conditions and in compliance with the prevailing laws.

 

Third: To delegate the Board of Directors in fulfilling all issuance procedures during the three years in accordance with the Companies Law No.159 for the year 1981 and Capital Market Law No. 95 for the year 1992 and their executive regulations.

 

Following is the issuance structure:

 

1) Value of the issuance:

A maximum of USD 1 Billion or its equivalent in Local/ Foreign Currency to be issued in one or more tranches through a public offering or a private placement either through local or international markets, in accordance with the decision of the Board of Directors.

 

2) Purpose of Issuance:

To strengthen the bank's capital base, to accommodate any future expansion and /or investments and/ or investments in Risk-Weighted Assets and/ or to finance the commercial banking activities, in accordance with the decision of the Board of Directors.

 

 

2/2

 

 

3) Face Value:

The Board of Directors will determine the face value per bond for each issuance locally and internationally.

 

4) Issuance fees and commission:

The Board of Directors will set the fees and commissions for the issuance of the financial instruments in Egyptian Pounds or foreign currency in accordance with the prevailing market conditions.

 

5) Rate of Return:

A fixed or floating rate of return will be determined by the Board of Directors for each issuance.

 

6) Coupon Tenor or Interest payment dates:

To be determined by the Board of Directors for each issuance

 

7) Minimum Subscription Amount:

 To be determined by the Board of Directors for each issuance.

 

8) Other Terms:

The General Assembly delegated the Board of Directors in fulfilling all necessary steps and procedures in relation to the issuance, dates and methods of issuance, currency for each tranche, returns, related fees and commissions, determining fees and commissions to be paid to foreign banks involved in the issuance in accordance to the international standards, determining any other terms for the issuance of the financial instruments, whether over one or more tranches and in amending any term as necessary provided that it is in compliance with the prevailing laws and delegating the CEO and Managing Director and/ or his Deputy or whomever he delegates in handling all administrative affairs and fulfilling all necessary procedures related to the issuance of the referred to financial instruments.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSEMFLIELSESD
Date   Source Headline
13th Nov 20087:00 amRNSInterim Management Statement
13th Nov 20087:00 amRNS3rd Quarter Results
5th Nov 20083:40 pmRNSPrice Monitoring Extension
31st Oct 20083:41 pmRNSPrice Monitoring Extension
24th Oct 20083:41 pmRNSPrice Monitoring Extension
20th Oct 20083:40 pmRNSPrice Monitoring Extension
10th Oct 20083:40 pmRNSPrice Monitoring Extension
9th Oct 20083:47 pmRNSSecond Price Monitoring Extn
9th Oct 20083:41 pmRNSPrice Monitoring Extension
2nd Oct 20083:46 pmRNSSecond Price Monitoring Extn
2nd Oct 20083:40 pmRNSPrice Monitoring Extension
1st Oct 20083:45 pmRNSSecond Price Monitoring Extn
1st Oct 20083:40 pmRNSPrice Monitoring Extension
30th Sep 20083:47 pmRNSSecond Price Monitoring Extn
30th Sep 20083:41 pmRNSPrice Monitoring Extension
17th Sep 200811:57 amRNSResponse to Market Rumour
8th Sep 20088:54 amRNSDirectorate Change
29th Aug 20083:40 pmRNSPrice Monitoring Extension
18th Aug 20083:45 pmRNSSecond Price Monitoring Extn
18th Aug 20083:40 pmRNSPrice Monitoring Extension
13th Aug 20087:00 amRNSDirectorate Change
13th Aug 20087:00 amRNSInterim Management Statement
13th Aug 20087:00 amRNSInterim Results
8th Aug 20083:40 pmRNSPrice Monitoring Extension
7th Aug 20083:40 pmRNSPrice Monitoring Extension
4th Aug 20088:50 amRNSHolding(s) in Company
16th Jul 20087:10 amRNSRe: Stock Dividend
30th Jun 20087:00 amRNSpress release
14th May 20087:36 amRNSAAIB Merger
12th May 20083:48 pmRNS1st Quarter Results
6th May 20083:45 pmRNSSecond Price Monitoring Extn
6th May 20083:40 pmRNSPrice Monitoring Extension
30th Apr 20082:01 pmRNSChanges in IR Team
18th Mar 20082:55 pmRNSAGM Statement
17th Mar 20087:00 amRNSFormal Notice
25th Feb 20087:00 amRNSFurther re Final Results
25th Feb 20087:00 amRNSFinal Results
25th Feb 20087:00 amRNSProposed Stock Dividend
12th Nov 20077:04 amRNS3rd Quarter Results
1st Oct 20077:02 amRNSStatement re Possible Offer
8th Aug 20077:00 amRNSInterim Results
31st May 20073:44 pmRNSPrice Monitoring Extension
14th May 20077:00 amRNS1st Quarter Results
15th Mar 200712:41 pmRNSDividend Declaration
6th Feb 20074:13 pmRNSFinal Results - Replacement
6th Feb 20078:56 amRNSFinal Results
15th Jan 20078:00 amRNSStatement re. Press Comment
6th Nov 20067:00 amRNS3rd Quarter Results
30th Oct 20069:44 amRNSStrategic Alliance
17th Oct 20061:08 pmRNSFormal Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.